A virilizing Leydig cell tumor of the ovary associated with stromal hyperplasia under gonadotropin control

Journal of Endocrinological Investigation

Volumn 20, Issue 11, 1997, Pages 685-689

  Marcondes, J A M ^a   Nery, M ^a   Mendonca B B ^a   Hayashida, S A Y ^a   Halbe, H W ^a   Carvalho, F M ^a   Wajchenberg, B L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endocrine function; Gonadotropin releasing hormone agonist; Leydig cell tumor; Ovarian hyperandrogenism; Ovarian tumor

Indexed keywords

DEXAMETHASONE; ETHINYLESTRADIOL; GONADORELIN; GONADOTROPIN; HYDROCORTISONE; TESTOSTERONE;

ADRENAL GLAND; ADULT; ARTICLE; CASE REPORT; FEMALE; FEMALE INFERTILITY; HAIR LOSS; HIRSUTISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPLASIA; INTRAMUSCULAR DRUG ADMINISTRATION; LAPAROTOMY; LEYDIG CELL TUMOR; MENSTRUAL IRREGULARITY; OVARIAN VEIN; OVARY TUMOR; SALPINGOOOPHORECTOMY; SYMPTOM; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

EID: 0031471935     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348033     Document Type: Article

References (12)

1. Scully R.E. Ovarian tumors with endocrine manifestation. In: DeGroot L., (Ed), Endocrinology. W. B. Saunders Company, Philadelphia, 1989, p. 1473
2. Marcondes J.A.M. Sindromes adrenogenitalis. In: Wajchenberg B.L. (Ed.), Tratado de endocrinologia clinica. Rocca, São Paulo, 1992, p. 483.
3. Kennedy L., Traub A.T., Atkinson A.B., Sheridan B. Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor. J. Clin. Endocrinol. Metab. 64: 1320, 1987.
4. Parr J.H., Abraham R.R., Seed M., Short F., Wynn V. The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist. J. Endocrinol. Invest. 11: 433, 1988.
5. Steingold K.A., Judd H.L., Nieberg R.K., Lu J.K.H., Chang R.J. Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist. Am. J. Obstet. Gynecol. 154: 1241, 1986.
6. Abraham G.E. Radioimmunoassay of steroids in biological material. Acta Endocrinol. (Copenh) (Suppl.) 1: 183, 1975.
7. Dunaif A., Scully R.E., Andersen R.N., Chapin D. S., Crowley Jr W.F. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in women: evidence from a luteinized thecoma of the ovary. J. Clin. Endocrinol. Metab. 59: 389, 1984.
8. Yen S.C.C. The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 12: 177, 1980.
9. Abrahamsson G., Dahlgren E., Hahtlin M., Knutson F., Norstrom A., Janson P.O. in vitro production of cyclic AMP and steroids from an ovarian Sertoli-Leydig cell tumor. Acta Obstet. Gynecol. Scand. 74: 310, 1995.
10. Lamberts S.W.J., Timmers J.M., Oosterom R. Testosterone secretion by culture arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist. J. Clin. Endocrinol. Metab. 54: 450, 1982.
11. Ory S.L. Clinical uses of luteinizing hormone-releasing hormone. Fertil. Steril. 39: 577, 1983.
12. 6-GnRH) in monthly injections. Norm. Metab. Res. 25: 105, 1993.